APDN logo

Applied DNA Sciences (APDN)

Profile

Full Name

Applied DNA Sciences, Inc.

Ticker Symbol

APDN

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

July 15, 2003

Indexes

Not included

Website

http://www.adnas.com

Employees

46

Key Details

Price

$0.92(-20.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.43M(-74.33% YoY)

Annual EPS

-$91.00(+88.03% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.92
APDN price is $0.92

30-Day Relative Volume

0.77
APDN 30-day relative volume is 0.77

Price Performance

Price Most recent change

-20%
APDN price was down -20% on Apr 14, 2025

Price YTD change

-90.8%
APDN price is down -90.8% since January 1st

Price 1-year change

-99.76%
APDN price is down -99.76% year-on-year

Price 3-year change

-99.95%
APDN price is down -99.95% over the past 3 years

Price Range

Price All-time high

$8520000.00
APDN price is currently -100.00% below its historical high of $8520000.00

Price 3-year low

$0.90
APDN price is currently +2.22% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.02M
APDN market capitalization is $1.02 million

Market cap 3-year change

-93.58%
APDN market capitalization is down -93.58% over the past 3 years

Market cap All-time high

$208.80M
APDN market capitalization is currently -99.51% below its historical high of $208.80 million

Market cap sector rank

3.95%
APDN market capitalization is higher than 3.95% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6280.35%
APDN shares outstanding is up +6280.35% year-on-year

Shares Outstanding 3-Year Change

+13360.98%
APDN shares outstanding is up +13360.98% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.89
APDN beta is 0.89

200-day SMA

$21.13
APDN price is currently -95.65% below its 200-day simple moving average

50-day SMA

$4.89
APDN price is currently -81.17% below its 50-day simple moving average

RSI

20.23
APDN 14-day relative strength index is 20.23

Volume

0.77
APDN 30-day relative volume is 0.77

ATR

$0.34
APDN average true range is $0.34

10-day Historical Volatility

137.39%
APDN 10-day historical volatility is 137.39%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.43M
APDN annual revenue is $3.43 million

Revenue Analysts estimate

$5.28M
APDN annual revenue is currently -35.06% lower than the consensus analysts' forecast

Revenue 1-year change

-74.33%
APDN annual revenue is down -74.33% year-on-year

Revenue Sector rank

19.26%
APDN annual revenue is higher than 19.26% of companies in Healthcare sector

EPS

EPS

-$91.00
APDN annual earnings per share is -$91.00

EPS Analysts estimate

-$24.00
APDN annual earnings per share is currently +279.17% higher than the consensus analysts' forecast

EPS 1-year change

+88.03%
APDN annual earnings per share is up +88.03% year-on-year

EPS Sector rank

2.23%
APDN annual earnings per share is higher than 2.23% of companies in Healthcare sector

Profit

Gross profit

$1.02M
APDN annual gross profit is $1.02 million

Gross margin

29.63%
APDN annual gross profit margin is 29.63%

Operating profit

-$14.02M
APDN annual operating income is -$14.02 million

Operating margin

-408.72%
APDN annual operating profit margin is -408.72%

Net income

-$6.99M
APDN annual net profit is -$6.99 million

Net margin

-203.78%
APDN annual net profit margin is -203.78%

Expenses

Total expenses

$17.46M
APDN annual total expenses is $17.46 million

Operating expenses

$15.04M
APDN annual total operating expenses is $15.04 million

Cost of goods sold

$2.41M
APDN annual cost of goods sold is $2.41 million

Selling, general & administrative expenses

$11.45M
APDN annual SGA is $11.45 million

Depreciation and amortization

$696.40K
APDN annual depreciation & amortization is $696.40 thousand

Interest expense

-
APDN annual interest expense value is unknown

Income tax

$0.00
APDN annual income tax is $0.00

EBIT & EBITDA

EBIT

-$14.02M
APDN annual earnings before interest & taxes is -$14.02 million

EBITDA

-$13.33M
APDN annual EBITDA is -$13.33 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.79M
APDN annual total assets is $12.79 million

Non current assets

$4.74M
APDN annual long term assets is $4.74 million

Current assets

$8.05M
APDN annual total current assets is $8.05 million

Cash and cash equivalents

$6.43M
APDN annual cash & cash equivalents is $6.43 million

Accounts receivable

$362.00K
APDN annual accounts receivable is $362.00 thousand

Inventory

$438.60K
APDN annual inventory is $438.60 thousand

Liabilities

Total liabilities

$3.82M
APDN annual total liabilities is $3.82 million

Long term liabilities

$1.42M
APDN annual total long term liabilities is $1.42 million

Current liabilities

$2.40M
APDN annual total current liabilities is $2.40 million

Accounts payable

$1.17M
APDN annual accounts payable is $1.17 million

Debt

Total debt

$739.10K
APDN annual total debt is $739.10 thousand

Total debt 1-year change

-40.29%
APDN annual total debt is down -40.29% year-on-year

Long term debt

$193.20K
APDN annual long term debt is $193.20 thousand

Short term debt

$545.90K
APDN annual short term debt is $545.90 thousand

Equity & Capital

Shareholders equity

$9.14M
APDN annual stockholders equity is $9.14 million

Book value

$9.14M
APDN annual book value is $9.14 million

Retained earnings

-$309.67M
APDN annual retained earnings is -$309.67 million

Working capital

$5.65M
APDN annual working capital is $5.65 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$13.71M
APDN annual cash flow from operations is -$13.71 million

Cash from operations 1-year change

-120.52%
APDN annual cash flow from operations is down -120.52% year-on-year

Cash from investing

-$407.90K
APDN annual cash flow from investing activities is -$407.90 thousand

Cash from investing 1-year change

+62.78%
APDN annual cash flow from investing activities is up +62.78% year-on-year

Cash from financing

$13.40M
APDN annual cash flow from financing activities is $13.40 million

Cash from financing 1-year change

+100%
APDN annual cash flow from financing activities is up +100% year-on-year

CAPEX

CAPEX

$407.90K
APDN annual capital expenditures is $407.90 thousand

CAPEX 1-year change

+420.28%
APDN annual capital expenditures is up +420.28% year-on-year

Free Cash Flow

Free cash flow

-$14.12M
APDN annual free cash flow is -$14.12 million

Free cash flow 1-year change

-124.25%
APDN annual free cash flow is down -124.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

29.63%
APDN annual gross profit margin is 29.63%

Operating margin

-408.72%
APDN annual operating profit margin is -408.72%

Net margin

-203.78%
APDN annual net profit margin is -203.78%

ROA & ROE

ROA

-52.89%
APDN annual return on assets is -52.89%

ROE

-101.04%
APDN annual return on equity is -101.04%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
APDN price to earnings ratio value is unknown

PE ratio Sector rank

-
APDN price to earnings ratio is unknown

PB Ratio

PB ratio

0.08
APDN price to book ratio is 0.08

PB ratio Sector rank

17.7%
APDN price to book ratio is higher than 17.7% of companies in Healthcare sector

PS Ratio

PS ratio

0.27
APDN price to sales ratio is 0.27

PS ratio Sector rank

9.49%
APDN price to sales ratio is higher than 9.49% of companies in Healthcare sector

Enterprise value

Enterprise value

-$7.67M
APDN enterprise value is -$7.67 million

Enterprise value Sector rank

5.54%
APDN enterprise value is higher than 5.54% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.60
APDN EV/EBITDA is 0.60

EV/EBITDA Sector rank

72.96%
APDN EV/EBITDA is higher than 72.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.36
APDN annual current ratio is 3.36

Quick ratio

3.17
APDN annual quick ratio is 3.17

Leverage

Debt to equity

0.00
APDN annual debt to equity ratio is 0.00

Interest coverage ratio

-
APDN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

3
APDN piotroski f-score is 3

Altman Z-Score

-36.56
APDN altman z-score is -36.56

Analyst ratings

Recent major analysts updates

Jun 10, 24 HC Wainwright & Co.
Buy
May 13, 24 HC Wainwright & Co.
Buy
Feb 9, 24 HC Wainwright & Co.
Buy
Dec 8, 23 HC Wainwright & Co.
Buy
Aug 24, 23 HC Wainwright & Co.
Buy
Aug 14, 23 HC Wainwright & Co.
Buy
Jul 14, 23 HC Wainwright & Co.
Buy
May 12, 23 HC Wainwright & Co.
Buy
May 8, 23 HC Wainwright & Co.
Buy
Mar 30, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

WINT logo
Windtree Therapeutics (WINT)
BIOR logo
Biora Therapeutics (BIOR)
DYNT logo
Dynatronics (DYNT)
TRVN logo
Trevena (TRVN)
AFIB logo
Acutus Medical (AFIB)
BDRX logo
Biodexa Pharmaceuticals (BDRX)
NEPT logo
Neptune Wellness Solutions (NEPT)
BIOC logo
Biocept (BIOC)
SLRX logo
Salarius Pharmaceuticals (SLRX)
  • What is the ticker symbol for Applied DNA Sciences?
  • Does Applied DNA Sciences pay dividends?
  • What sector is Applied DNA Sciences in?
  • What industry is Applied DNA Sciences in?
  • What country is Applied DNA Sciences based in?
  • When did Applied DNA Sciences go public?
  • Is Applied DNA Sciences in the S&P 500?
  • Is Applied DNA Sciences in the NASDAQ 100?
  • Is Applied DNA Sciences in the Dow Jones?
  • When was Applied DNA Sciences's last earnings report?
  • When does Applied DNA Sciences report earnings?
  • Should I buy Applied DNA Sciences stock now?

What is the ticker symbol for Applied DNA Sciences?

The ticker symbol for Applied DNA Sciences is NASDAQ:APDN

Does Applied DNA Sciences pay dividends?

No, Applied DNA Sciences does not pay dividends

What sector is Applied DNA Sciences in?

Applied DNA Sciences is in the Healthcare sector

What industry is Applied DNA Sciences in?

Applied DNA Sciences is in the Diagnostics & Research industry

What country is Applied DNA Sciences based in?

Applied DNA Sciences is headquartered in United States

When did Applied DNA Sciences go public?

Applied DNA Sciences's initial public offering (IPO) was on July 15, 2003

Is Applied DNA Sciences in the S&P 500?

No, Applied DNA Sciences is not included in the S&P 500 index

Is Applied DNA Sciences in the NASDAQ 100?

No, Applied DNA Sciences is not included in the NASDAQ 100 index

Is Applied DNA Sciences in the Dow Jones?

No, Applied DNA Sciences is not included in the Dow Jones index

When was Applied DNA Sciences's last earnings report?

Applied DNA Sciences's most recent earnings report was on Feb 13, 2025

When does Applied DNA Sciences report earnings?

The next expected earnings date for Applied DNA Sciences is May 9, 2025

Should I buy Applied DNA Sciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page